EC

Elmind Capital Portfolio holdings

AUM $352M
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
–
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$352M
AUM Growth
+$13.4M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
36
New
Increased
Reduced
Closed

Top Buys

1
+$19.5M
2
+$5.54M
3
+$3.55M
4
ALMS
Alumis Inc
ALMS
+$3.25M
5
CGEM icon
Cullinan Oncology
CGEM
+$2.83M

Top Sells

1
+$11.4M
2
+$10.5M
3
+$9.61M
4
BCRX icon
BioCryst Pharmaceuticals
BCRX
+$8.93M
5
WVE icon
Wave Life Sciences
WVE
+$3.52M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DSGN icon
26
Design Therapeutics
DSGN
$653M
$2.21M 0.63%
207,900
APLS
27
DELISTED
Apellis Pharmaceuticals
APLS
$2.01M 0.57%
50,000
ALEC icon
28
Alector
ALEC
$239M
$1.94M 0.55%
900,000
IMCR icon
29
Immunocore
IMCR
$1.45B
$1.76M 0.5%
58,248
AMLX icon
30
Amylyx Pharmaceuticals
AMLX
$1.56B
$1.56M 0.44%
112,000
ENGN icon
31
enGene Therapeutics
ENGN
$122M
$1.43M 0.41%
210,000
WVE icon
32
Wave Life Sciences
WVE
$1.27B
$1.29M 0.37%
177,846
-270,000
SUPN icon
33
Supernus Pharmaceuticals
SUPN
$2.68B
$1.03M 0.29%
20,000
EWTX icon
34
Edgewise Therapeutics
EWTX
$3.67B
$315K 0.09%
10,000
-20,000
DVAX
35
DELISTED
Dynavax Technologies
DVAX
– –
-679,900
LQDA icon
36
Liquidia Corp
LQDA
$5.45B
– –
-90,000
1
2